Interpreting Post‐Discontinuation Trajectories After Semaglutide or Tirzepatide

Key Points

• This research aims to analyze the trajectories experienced by subjects following the discontinuation of semaglutide or tirzepatide treatment.
• Analysis of post-treatment participant data
• Comparative evaluation of trajectories for semaglutide and tirzepatide
• Statistical evaluation of discontinuation effects
• Identified distinct patterns of weight change after treatment discontinuation
• Noted variability in individual experiences post-discontinuation
• Revealed implications for clinical management of weight loss therapies